BPG致力于知识发现和传播
预出版
2021/6/21 3:13:53 | Browse: 184 | 下载: 229
| Publication Name |
世界华人消化杂志 |
| 手稿编号 |
38328 |
| 手稿来源省、自治区或特别行政区 |
云南省 |
| 专业类型 |
消化内科学 |
| 手稿栏目类型 |
文献综述 |
| 文章标题 |
炎症性肠病治疗中生物制剂的个体化选择
|
| 手稿来源 |
约稿 |
| 所有作者列表 |
容加梅, 罗娟, 黄奇, 缪应雷 |
| 基金项目及其编号 |
| 基金项目名称 |
基金编号 |
| 热休克转录因子2调控线粒体自噬在溃疡性结肠炎中的作用机制研究 |
81670501 |
|
| 通讯作者 |
缪应雷, 博士, 主任医师, 650032, 昆明市西昌路295号, 云南省昆明医科大学第一附属医院消化内科. myldu@sina.com |
| 关键词 |
炎症性肠病; 生物制剂; 个体化 |
| 核心内容提要 |
炎症性肠病(inflammatory bowel disease，IBD)是一种慢性肠道炎症性疾病, 病情反复,需终身治疗. 目前针对不同的分子通路, 已经开发出多种治疗IBD的新型生物制剂. 我们需要把患者疾病特点与药物特征相结合, 充分权衡风险与获益, 为IBD患者制定个体化的治疗方案. |
| 引文著录 |
容加梅, 罗娟, 黄奇, 缪应雷. 炎症性肠病治疗中生物制剂的个体化选择. 世界华人消化杂志 2021; 29(15): 893-900 |
 |
Received |
|
2021-04-30 07:56 |
|
Peer-Review Started |
|
2021-04-30 10:36 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-13 03:40 |
|
修回稿 |
|
2021-05-19 09:23 |
|
Second Decision |
|
2021-06-18 10:43 |
|
期刊总编辑接受 |
|
|
|
公司总编辑接受 |
|
2021-06-21 03:13 |
|
预出版 |
|
2021-06-21 03:13 |
|
缴纳版面费 |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
排版 |
|
2021-08-09 03:45 |
| ISSN |
1009-3079 (print) and 2219-2859 (online) |
| 开放获取 |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| 版权 |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| 网址 |
http://www.wjgnet.com |
| Assistant Editor |
张砚梁 |
| Science Editor |
张砚梁 |
| 评议人编号 |
03656501, 03656549, 03737312, and 03656357 |
| Editorial Director |
|
| Journal Chief Editor |
|
| Company Chief Editor |
马俐 |
| Language Editor |
|
| Production Editor |
张砚梁 |
| Responsible Production Editor |
张砚梁 |
| Responsible Science Editor |
|
| Proofing Editorial Director |
Jin-Lei Wang |
| Proofing Editor-in-Chief |
Lian-Sheng Ma |
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
